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Upon encounter with antigen, long-lived B lymphocytes
differentiate into short-lived plasma cells, the terminal
effectors of the humoral immune response. Plasma cells
are specialized in immunoglobulin (Ig) secretion, each of
them being capable of releasing thousands of molecules
per second. We have performed proteomics analyses to
unravel mechanistically the massive de novo ER biogenesis
during terminal plasma cell differentiation, with empha-
sis on how cells adapt ER quality control to exuberant Ig
production and secretion. These studies revealed that
waves of functionally related proteins are produced to
increase the capacity of the antibody factory, and led to
the identification of novel ER chaperones. As to the mech-
anisms that lead to plasma cell death, we show that in the
late phases of plasmacytic differentiation, when antibody
production becomes maximal, proteasomal activity unex-
pectedly decreases. The excessive load for the reduced pro-
teolytic capacity correlates with accumulation of
polyubiquitinated proteins, stabilization of endogenous
proteasomal substrates (including Xbp1s, Ik-Bα and Bax),
onset of apoptosis, and sensitization to proteasome inhib-
itors. A developmental program seems therefore to link
plasma cell death to protein production, explaining the
peculiar sensitivity of normal and malignant plasma cells
to proteasome inhibitors.
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